Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHR8008 vs fluconazole for acute vulvovaginal candidiasis
CTR20210733Phase 3Completed
- Sponsor
- eVenus Pharmaceutical Laboratories
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of oteseconazole in vulvovaginal candidiasis (VVC), sponsored by eVenus Pharmaceutical Laboratories. Started Apr 2021; status: completed.
02
Drugs
oteseconazole
03
Conditions
vulvovaginal candidiasis (VVC)
Beyond the preview
Go deeper on CTR20210733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210733.